Radiopaque contrast media. XXVII. Pharmacologic properties of iodoxamic acid, a new contrast medium for intravenous cholegraphy.
D000577:Amides / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D001659:Biliary Tract / Q000187:drug effects / Q000378:metabolism; D002415:Cats; D002758:Cholangiography; D003287:Contrast Media / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D004285:Dogs; D005019:Ethyl Ethers / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D006016:Glycolates / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D007275:Injections, Intravenous; D007458:Iodipamide / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D007463:Iodobenzoates / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D011485:Protein Binding; D011817:Rabbits; D051381:Rats
D000577:Amides; D003287:Contrast Media; D005019:Ethyl Ethers; D006016:Glycolates; D007463:Iodobenzoates; D007458:Iodipamide